Targeted Application of Human Genetic Variation Can Improve Red Blood Cell Production from Stem Cells.

导出 OA

翻译打印收藏纠错

作者： Felix C,Giani ^[1] ; Claudia,Fiorini ^[2] ; Aoi,Wakabayashi ^[3] ; Leif S,Ludwig ^[1] ; Rany M,Salem ^[2] ; Chintan D,Jobaliya ^[1] ; Stephanie N,Regan ^[2] ; Jacob C,Ulirsch ^[1] ; Ge,Liang ^[2] ; Orna,Steinberg-Shemer ^[3] ; Michael H,Guo ^[4] ; Tõnu,Esko ^[2] ; Wei,Tong ^[5] ; Carlo,Brugnara ^[6] ; Joel N,Hirschhorn ^[2] ; Mitchell J,Weiss ^[7] ; Leonard I,Zon ^[1] ; Stella T,Chou ^[2] ; Deborah L,French ^[6] ; Kiran,Musunuru ^[6] ; Vijay G,Sankaran ^[2]

作者单位： Division of Hematology/Oncology, Boston Children's Hospital and Department of Pediatric Oncology, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA 02115, USA. ^[1] Broad Institute of MIT and Harvard, Cambridge, MA 02142, USA. ^[2] Department of Neonatology, Charité-Universitätsmedizin Berlin, Berlin 10117, Germany. ^[3] Institute for Chemistry and Biochemistry, Freie Universität Berlin, Berlin 14195, Germany. ^[4] Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. ^[5] Departments of Pathology and Laboratory Medicine and Pediatrics, The Children's Hospital of Philadelphia, University of Pennsylvania, Philadelphia, PA 19104, USA. ^[6] Department of Stem Cell and Regenerative Biology, Harvard University, Cambridge, MA 02138, USA. ^[7] Department of Laboratory Medicine, Boston Children's Hospital, Harvard Medical School, Boston, MA 02115, USA. ^[8] Department of Hematology, St. Jude Children's Research Hospital, Memphis, TN 38105, USA. ^[9]